Bleeding Disorders Treatment Market (Disease Type - Hemophilia A, Hemophilia B, Von Willebrand Disease, and Other Disease Types; Drug Class - Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Antibrinolytics, Desmopressin, Fibrin Sealant, and Other Drug Classes; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Compounding Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : June, 2019

  • Rep Id : HC0028

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on bleeding disorders treatment market provides an in-depth analysis of segments and sub-segments in the global as well as regional bleeding disorders treatment market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional bleeding disorders treatment market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global bleeding disorders treatment market. According to the report, the global bleeding disorders treatment market is projected to grow at a CAGR of 7.8% over the forecast period of 2019-2025.


Market Insight

A bleeding disorder is a medical situation in which normal clotting function of blood is adversely affected. The clotting function is also known as coagulation in which blood changes from liquid to a solid state. The bleeding disorder can cause anomalous bleeding outside and inside the body. The most common type of bleeding disorder is von Willebrand disease (VWD) in women. There are different bleeding disorders treatment are available which includes iron supplementation, fresh frozen plasma, platelet transfusion, and antifibrinolytic drugs.


Hemophilia is the most well-known inherited bleeding disorder in which the blood does not clot properly. The growing incidences of hemophilia across the world escalate the demand for bleeding disorders treatment market. As per Hemophilia Federation of America, four hundred thousand people worldwide were living with hemophilia, and about 20,000 are living with it in the United States. Moreover, growing R&D investment for the development of hemophilia products, rising awareness about bleeding disorders and favorable compensation policies is another factor responsible for the growth of the same. Furthermore, according to the Centers for Disease Control and Prevention, near about 400 babies were born with hemophilia Each year. However, the high cost of hemophilia drugs may hamper the growth of bleeding disorders treatment market. Availability of cheap generic drugs is expected to provide growth opportunities in the countries of Latin America, the Middle East, and Africa.


On the basis regions, North America is accounted to hold the largest share in the bleeding disorder treatment market due to highly developed infrastructures. As per National Hemophilia Foundation, VWD is believed to be the most common bleeding disorder. It is estimated to affect up to 1% of the US population. The Asia Pacific region is anticipated to be the highest growth rate during the forecast period. The growth of this region is attributed due to growing awareness of bleeding disorders in emerging countries such as China and India and development in healthcare infrastructures.

Global Bleeding Disorders Treatment Market


Segment Covered

The report on global bleeding disorders treatment market covers segments such as disease type, drug class, and distribution channel. On the basis of disease type, the sub-markets include hemophilia a, hemophilia b, von willebrand disease, and other disease types. On the basis of drug class, the sub-markets include plasma derived coagulation factor concentrates, recombinant coagulation factor concentrates, antibrinolytics, desmopressin, fibrin sealant, and other drug classes. On the basis of distribution channel, the sub-markets include hospital pharmacies, retail pharmacies, and compounding pharmacies.


Companies Profiled:

The report provides profiles of the companies in the market such as Compounding Pharmacies Bioverativ Inc., Janssen Global Services, LLC, Amgen Inc., Sanofi S.A., Bristol-Myers Squibb Company, Xenetic Biosciences, Inc., Pfizer Inc., Alnylam Pharmaceuticals Inc., Baxter International Inc., and Bayer AG.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of bleeding disorders treatment market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount